Cam Group Holding A decreased its stake in Ultragenyx Pharmaceutical In (RARE) by 50.92% based on its latest 2018Q4 regulatory filing with the SEC. Cam Group Holding A sold 22,585 shares as the company’s stock rose 19.90% with the market. The institutional investor held 21,765 shares of the major pharmaceuticals company at the end of 2018Q4, valued at $946,000, down from 44,350 at the end of the previous reported quarter. Cam Group Holding A who had been investing in Ultragenyx Pharmaceutical In for a number of months, seems to be less bullish one the $3.76 billion market cap company. The stock decreased 3.15% or $2.14 during the last trading session, reaching $65.8. About 408,232 shares traded. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) has risen 36.36% since March 14, 2018 and is uptrending. It has outperformed by 31.99% the S&P500. Some Historical RARE News: 07/03/2018 – ULTRAGENYX PHARMACEUTICAL INC – COHORT 2 PATIENT ENROLLMENT TO BEGIN IN MARCH 2018; DATA EXPECTED IN SECOND HALF OF 2018; 17/04/2018 – FDA: New/Generic Drug Approvals – ULTRAGENYX PHARM INC – Biologic License Application (BLA): 761068 April 17, 2018; 23/04/2018 – ULTRAGENYX ANNOUNCES FILING AND FDA CLEARANCE OF AN INVESTIGATIONAL NEW DRUG APPLICATION FOR DTX401, A GENE THERAPY FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE IA; 07/03/2018 – ULTRAGENYX: UREAGENESIS NORMALIZED IN ONE PATIENT, UP BY 24 WKS; 22/04/2018 – DJ Ultragenyx Pharmaceutical Inc, Inst Holders, 1Q 2018 (RARE); 23/04/2018 – ULTRAGENYX PHARMACEUTICAL INC – ENROLLMENT IN PHASE 1/2 STUDY OF DTX401 TO BEGIN IN H1 2018, WITH DATA FROM FIRST COHORT EXPECTED IN H2 OF 2018; 30/05/2018 – Rentschler Fill Solutions and Ultragenyx start fill & finish collaboration for the US commercial supply of drug product Mepsevii; 07/05/2018 – Ultragenyx Pharma 1Q EPS 62c; 17/05/2018 – ULTRAGENYX & KYOWA KIRIN REPORT TOPLINE PHASE 3 STUDY RESULTS; 30/04/2018 – Ultragenyx and Kyowa Kirin Announce Crysvita® (burosumab-twza) Now Launched in the U.S. for the Treatment of X–linked Hypoph

American International Group Inc decreased its stake in Ulta Beauty Inc (ULTA) by 4.83% based on its latest 2018Q4 regulatory filing with the SEC. American International Group Inc sold 1,332 shares as the company’s stock rose 5.54% with the market. The institutional investor held 26,241 shares of the 2007 company at the end of 2018Q4, valued at $6.43 million, down from 27,573 at the end of the previous reported quarter. American International Group Inc who had been investing in Ulta Beauty Inc for a number of months, seems to be less bullish one the $18.54B market cap company. The stock decreased 0.93% or $2.93 during the last trading session, reaching $312.51. About 903,284 shares traded or 16.57% up from the average. Ulta Beauty, Inc. (NASDAQ:ULTA) has risen 55.20% since March 14, 2018 and is uptrending. It has outperformed by 50.83% the S&P500. Some Historical ULTA News: 15/03/2018 – Ulta Beauty Sees 1Q EPS $2.43-EPS $2.48; 23/03/2018 – The New League: Ulta Beauty’s Masstige Players; 21/03/2018 – The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of Ulta Beauty, Inc. Shareholders and a Lead Plaintiff; 10/03/2018 – Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Filed Against Ulta Beauty, Inc. – Ulta; 15/03/2018 – After-hours buzz: ADBE, AVGO, ULTA & more; 09/03/2018 – The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Ulta; 15/03/2018 – ULTA BEAUTY INC – COMPANY APPROVES NEW SHARE REPURCHASE AUTHORIZATION OF $625 MLN; 15/03/2018 – Ulta Beauty 4Q Adj EPS $2.75; 21/03/2018 – Ulta Refutes Reselling Lawsuit, Saying ‘Third Parties’ May Be to Blame; 09/03/2018 – The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Ulta Beauty, Inc

More notable recent Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) news were published by: Nasdaq.com which released: “Canada Rare Earth â€“ In the Business of Rare Earths â€“ February 2019 Corporate Update – Nasdaq” on February 28, 2019, also Nasdaq.com with their article: “Rare disease biotech Mereo BioPharma officially withdraws $70 million US IPO – Nasdaq” published on February 21, 2019, Nasdaq.com published: “Albireo Recognizes Rare Disease Day and Highlights Urgent Need to Support Families Affected by Progressive Familial Intrahepatic Cholestasis (PFIC) – Nasdaq” on February 28, 2019. More interesting news about Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) were released by: Nasdaq.com and their article: “Chiasma to Participate in Three Investor Conferences in March – Nasdaq” published on March 04, 2019 as well as Nasdaq.com‘s news article titled: “In rare move, U.S. judge orders acquittal of Barclays currency trader – Nasdaq” with publication date: March 04, 2019.

Cam Group Holding A, which manages about $6.91B US Long portfolio, upped its stake in Alphabet Inc by 1,245 shares to 486,916 shares, valued at $504.26 million in 2018Q4, according to the filing. It also increased its holding in At&T Inc (NYSE:T) by 21,877 shares in the quarter, for a total of 77,219 shares, and has risen its stake in Aramark (NYSE:ARMK).